CN Stock MarketDetailed Quotes
603301 Zhende Medical
- 21.84
- +0.32+1.49%
Market Closed May 31 15:00 CST
5.82BMarket Cap46.47P/E (TTM)
22.05High21.59Low8.69KlotVolume21.59Open21.52Pre Close19.01MTurnover0.33%Turnover Ratio29.32P/E (Static)266.45MShares31.9552wk High1.06P/B5.82BFloat Cap15.6852wk Low23.67Limit Up266.45MShs Float101.71Historical High19.37Limit Down2.14%Amplitude8.38Historical Low1.50Dividend TTM21.88Avg Price3.10KlotAsk6.87%Div YieldTTM100Lot Size5.39KlotBid
Zhende Medical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -23.41%1.01B | -30.74%4.51B | -23.53%3.55B | -14.31%2.54B | -6.98%1.32B | 19.39%6.51B | 11.02%4.64B | -8.18%2.96B | -29.11%1.42B | -49.12%5.46B |
| Refunds of taxes and levies | -31.76%27.02M | -26.71%167.14M | -19.54%110.45M | 47.37%75M | 46.29%39.6M | 9.97%228.04M | -4.58%137.27M | -55.10%50.89M | -67.42%27.07M | 9.15%207.37M |
| Cash received relating to other operating activities | -74.87%9.18M | 3.72%183.18M | 50.61%162.09M | 419.67%146.02M | 403.03%36.54M | -37.13%176.6M | -48.17%107.62M | -80.76%28.1M | -97.52%7.26M | 48.08%280.9M |
| Cash inflows from operating activities | -24.99%1.05B | -29.73%4.86B | -21.78%3.82B | -9.27%2.76B | -3.94%1.4B | 16.39%6.92B | 7.81%4.89B | -12.75%3.04B | -38.86%1.45B | -46.46%5.94B |
| Goods services cash paid | -32.91%641.09M | -32.04%2.72B | -33.88%2.25B | -22.15%1.67B | 0.44%955.62M | 28.68%4B | 39.56%3.4B | 15.63%2.15B | -18.55%951.43M | -50.25%3.11B |
| Staff behalf paid | -32.65%222.58M | -0.04%1B | 1.78%766.26M | 13.79%574.11M | 33.73%330.47M | 20.31%1B | 38.77%752.85M | 22.42%504.53M | 2.75%247.12M | 39.19%834.49M |
| All taxes paid | -69.52%64.46M | 24.57%331.72M | 80.02%286.76M | 88.89%220.93M | 304.20%211.48M | -61.01%266.3M | -75.52%159.29M | -79.27%116.96M | -78.17%52.32M | 26.12%683.01M |
| Cash paid relating to other operating activities | -10.91%93.91M | -11.62%357.24M | -5.37%259.46M | -11.22%166.57M | 23.04%105.4M | -19.51%404.22M | -29.71%274.19M | -40.21%187.61M | -82.94%85.67M | -15.83%502.21M |
| Cash outflows from operating activities | -36.24%1.02B | -22.27%4.41B | -22.37%3.56B | -10.93%2.63B | 19.94%1.6B | 10.65%5.67B | 14.10%4.59B | -6.06%2.96B | -37.84%1.34B | -35.78%5.13B |
| Net cash flows from operating activities | 112.80%26.3M | -63.72%452.11M | -12.89%262.85M | 48.43%126.57M | -273.44%-205.37M | 52.40%1.25B | -41.35%301.74M | -74.84%85.27M | -48.42%118.41M | -73.80%817.63M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | 376.95%410.62M | -59.92%100M | 1,968.09%100M | ---- | -91.56%86.09M | -58.99%249.53M | -99.13%4.84M | -98.48%7.59M | 19.03%1.02B |
| Cash received from returns on investments | ---- | ---- | 618.33%2.44M | --2.44M | ---- | -57.26%359.67K | -98.38%339.3K | ---- | -99.56%20.37K | -94.42%841.59K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 31.65%12.61M | -97.35%233.64K | -97.46%220.14K | 533.30%162.44K | 41.24%9.58M | 2,516.99%8.81M | 1,660.28%8.66M | -82.25%25.65K | -89.98%6.78M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --51.57M | --1.57M | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | 647.71%7.4M | ---- | ---- | ---- | -99.58%989.69K | ---- | ---- | ---- | --234.52M |
| Cash inflows from investing activities | ---- | 189.82%430.64M | -60.55%102.67M | 660.58%102.66M | -97.87%162.44K | -88.23%148.59M | -69.73%260.25M | -98.32%13.5M | -98.49%7.63M | 34.31%1.26B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 52.82%161.46M | -20.54%599.24M | -39.53%370.84M | -42.46%240.99M | -55.97%105.65M | 8.43%754.12M | 50.18%613.26M | 27.42%418.84M | 26.32%239.93M | -36.36%695.47M |
| Cash paid to acquire investments | -99.70%501.5K | 88.22%569.87M | 92.89%474.75M | 37,254.44%466.93M | 334,267.30%167.18M | -47.40%302.77M | -8.28%246.12M | -99.13%1.25M | -99.95%50K | -56.19%575.65M |
| Net cash paid to acquire subsidiaries and other business units | -57.61%48.66M | 304.62%311.91M | --312.31M | --239.32M | --114.8M | -85.87%77.09M | ---- | ---- | ---- | 490.85%545.54M |
| Cash paid relating to other investing activities | ---- | 0.95%7.47M | ---- | ---- | ---- | --7.4M | --24.63M | --1.65M | ---- | ---- |
| Adjustment items of investing cash outflows | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -45.66%210.63M | 30.41%1.49B | 30.98%1.16B | 124.60%947.24M | 61.53%387.64M | -37.17%1.14B | -1.47%884.02M | -10.71%421.74M | -17.23%239.98M | -33.46%1.82B |
| Adjustment items of net investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 |
| Net cash flows from investing activities | 45.64%-210.63M | -6.55%-1.06B | -69.17%-1.06B | -106.88%-844.58M | -66.76%-387.48M | -79.07%-992.79M | -1,565.87%-623.77M | -223.04%-408.24M | -207.99%-232.35M | 69.03%-554.42M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | 1,839.84%1.02B | --968.24M | ---- | ---- | --52.5M |
| Cash from borrowing | 110.84%1.13B | -50.14%916.9M | -57.72%564.9M | -58.47%554.9M | 37.51%534.9M | 107.78%1.84B | 53.39%1.34B | 140.72%1.34B | 55.60%389M | -6.35%885M |
| Cash received relating to other financing activities | ---- | -51.20%20.28M | --20.17M | --20.17M | ---- | --41.55M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 110.84%1.13B | -67.67%937.18M | -74.61%585.07M | -56.96%575.07M | 37.51%534.9M | 209.21%2.9B | 149.63%2.3B | 119.92%1.34B | 55.58%389M | -0.79%937.5M |
| Borrowing repayment | 716.33%400M | -53.58%916.79M | -67.78%434.29M | -89.40%75.29M | -80.40%49M | 270.54%1.98B | 152.91%1.35B | 56.73%710M | -27.54%250M | -40.25%533M |
| Dividend interest payment | -32.86%6.94M | 27.16%423.72M | -33.08%222.38M | -32.46%216.45M | 42.77%10.34M | -40.01%333.21M | -38.31%332.33M | 4,245.16%320.46M | 204.50%7.25M | 95.26%555.42M |
| -Including:Cash payments for dividends or profit to minority shareholders | -97.50%100K | ---- | --5M | -97.04%5M | --4M | --168.96M | ---- | --168.96M | ---- | ---- |
| Cash payments relating to other financing activities | 1,621.70%22.58M | -85.18%19.95M | --2.71M | --2.08M | --1.31M | -41.11%134.65M | ---- | ---- | ---- | 395.93%228.65M |
| Cash outflows from financing activities | 608.14%429.53M | -44.31%1.36B | -60.76%659.38M | -71.49%293.83M | -76.42%60.66M | 85.48%2.44B | 39.44%1.68B | 73.55%1.03B | -46.56%257.25M | 7.72%1.32B |
| Net cash flows from financing activities | 47.23%698.23M | -192.83%-423.28M | -111.91%-74.31M | -7.95%281.24M | 259.94%474.24M | 220.14%456M | 321.22%623.9M | 2,123.31%305.53M | 156.95%131.75M | -36.70%-379.57M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 232.76%11.07M | 446.39%12.81M | 121.88%11.69M | 142.27%20.9M | 80.00%-8.34M | 90.34%-3.7M | -1,009.50%-53.44M | -415.43%-49.44M | -4,559.60%-41.67M | 60.38%-38.29M |
| Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 |
| Net increase in cash and cash equivalents | 513.56%524.97M | -244.03%-1.02B | -444.17%-855M | -521.81%-415.88M | -432.22%-126.94M | 556.23%705.55M | 30.62%248.43M | -109.91%-66.88M | -111.13%-23.85M | -116.17%-154.65M |
| Add:Begin period cash and cash equivalents | -49.32%1.04B | 52.07%2.06B | 52.07%2.06B | 52.07%2.06B | 52.07%2.06B | -10.24%1.36B | -10.37%1.36B | -10.24%1.36B | -9.64%1.36B | 172.82%1.51B |
| End period cash equivalent | -18.84%1.57B | -49.32%1.04B | -24.81%1.21B | 27.68%1.64B | 45.26%1.93B | 52.07%2.06B | -5.79%1.6B | -41.03%1.29B | -22.33%1.33B | -10.24%1.36B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg